SCHEMBL18954783

SCHEMBL18954783

O=C(O)c1ccccc1CN1C(=O)C(=O)c2cccc(Br)c21

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CTRC Q99895 1/20 0.52
▸ ALDH1A1 P00352 7/20 0.50
▸ ALDH3A1 P30838 4/20 0.50
▸ PARK7 Q99497 2/20 0.44
▸ CHRM5 P08912 3/20 0.44
▸ TGM2 P21980 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ALDH2 P05091 2/20 0.41
▸ CES1 P23141 2/20 0.40
▸ CHRM1 P11229 2/20 0.40
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954806 0.88 PARK7 (0.60) CTRCALDH1A1ALDH3A1PARK7CHRM5
SCHEMBL18954698 0.85 MAPT (0.56) ALDH1A1TGM2KMT2ATP53MAPT
SCHEMBL18954828 0.85 CHRM5 (0.54) ALDH1A1ALDH3A1PARK7CHRM5TGM2
SCHEMBL18954872 0.85 CHRM5 (0.55) ALDH1A1ALDH3A1PARK7CHRM5TGM2
SCHEMBL18955196 0.81 GAA (0.48) ALDH1A1PARK7CHRM5TGM2KMT2A
SCHEMBL18954595 0.81 CHRM5 (0.53) ALDH1A1ALDH3A1PARK7CHRM5TGM2
SCHEMBL18974327 0.81 CES1 (0.62) ALDH1A1ALDH3A1PARK7CHRM5TGM2
SCHEMBL18954751 0.80 ALDH1A1 (0.67) ALDH1A1ALDH3A1PARK7CHRM5ALDH2
SCHEMBL27881830 0.79 ALDH1A1 (0.64) CTRCALDH1A1ALDH3A1PARK7CHRM5
SCHEMBL18954567 0.79 ALDH1A1 (0.55) ALDH1A1ALDH3A1PARK7CHRM5TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback